| RS886041342 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS886041343 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS886041344 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886041345 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS886041346 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS886041347 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS886041348 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS886041349 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS886041350 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS886041351 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS886041352 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Partial androgen insensitivity syndrome |
| RS886041353 |
SERPING1
|
Health Risk |
Likely pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS886041354 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS886041355 |
FOXC1
|
Health Risk |
Likely pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS886041356 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS886041357 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041358 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041359 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041360 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041361 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041362 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, See cases |
| RS886041363 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Hypophosphatemic rickets |
| RS886041364 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041365 |
PHEX
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS886041366 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041367 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041368 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041369 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Hypophosphatemic rickets |
| RS886041370 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS886041371 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041372 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041373 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041374 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Hypophosphatemic rickets |
| RS886041375 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041376 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS886041377 |
RNASEH2B
|
Health Risk |
Pathogenic |
— |
| RS886041378 |
SOX2
|
Health Risk |
Pathogenic |
— |
| RS886041379 |
WAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiskott-Aldrich syndrome, Thrombocytopenia 1 |
| RS886041380 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS886041381 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS886041382 |
WDR45
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neurodegeneration with brain iron accumulation 5 |
| RS886041383 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS886041384 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS886041386 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4A |
| RS886041387 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS886041389 |
FUS
|
Health Risk |
Pathogenic |
— |
| RS886041390 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS886041391 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS886041392 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS886041394 |
ALOX12B
|
Health Risk |
Pathogenic |
— |
| RS886041395 |
PRDM16
|
Health Risk |
Pathogenic |
Left ventricular noncompaction 8, Left ventricular noncompaction cardiomyopathy |
| RS886041396 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, Inborn genetic diseases |
| RS886041397 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS886041398 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS886041399 |
HBA2
|
Health Risk |
Pathogenic |
alpha Thalassemia, Erythrocytosis |
| RS886041400 |
RASA1
|
Health Risk |
Pathogenic |
RASA1-related disorder, Capillary malformation-arteriovenous malformation syndrome |
| RS886041401 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS886041402 |
CARD14
|
Health Risk |
Pathogenic |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS886041404 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS886041405 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS886041406 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886041408 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886041410 |
CRYBB2
|
Health Risk |
Pathogenic |
Developmental cataract, Cataract 3 multiple types |
| RS886041411 |
NFKBIA
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 2, Ectodermal dysplasia and immunodeficiency 2 |
| RS886041412 |
EPHA2
|
Health Risk |
Pathogenic |
Cataract 6 multiple types, Inborn genetic diseases |
| RS886041414 |
RIT1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 8, Noonan syndrome and Noonan-related syndrome |
| RS886041415 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS886041416 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886041417 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS886041420 |
LHX4
|
Health Risk |
Pathogenic |
— |
| RS886041421 |
IFT122
|
Health Risk |
Pathogenic |
— |
| RS886041422 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS886041426 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS886041427 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS886041428 |
SPRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Legius syndrome, Cardiovascular phenotype |
| RS886041429 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS886041430 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS886041431 |
ATP1A3
|
Health Risk |
Pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS886041432 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS886041433 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS886041434 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886041435 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS886041436 |
CENPF
|
Health Risk |
Pathogenic |
Stromme syndrome, Stromme syndrome |
| RS886041437 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome 1, Knobloch syndrome 1 |
| RS886041438 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS886041439 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS886041440 |
FBN1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS886041441 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886041442 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041443 |
RET
|
Health Risk |
Pathogenic |
— |
| RS886041444 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS886041445 |
RPL15
|
Health Risk |
Pathogenic |
— |
| RS886041446 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041447 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS886041448 |
MED13L
|
Health Risk |
Pathogenic |
Intellectual disability, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS886041449 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS886041450 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS886041451 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS886041452 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS886041453 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |